1
Eric First, M.D.
Eric R First: Application of botulinum toxin to the management of neurogenic inflammatory disorders. Thomas J Nutter McClennen & Fish Engellenner, May 16, 2000: US06063768 (149 worldwide citation)

The present invention provides a method for the use of at least one serotype or a combination of serotypes of Botulinum neurotoxin either alone or in combination with other peptides or fusion proteins, that when administered in a safe and effective amount, antagonize and therefore decrease or block ...


2
Eric First, M.D.
L Bruce Pearce, Eric R First: Compositions and methods for chemodenervation using neurotoxins. Thomas J Engellenner, Nutter McClennen & Fish, July 11, 2000: US06087327 (34 worldwide citation)

The compositions and methods disclosed herein utilize admixtures of neurotoxins to cause denervation which is unexpectedly more localized and of longer duration than otherwise occurs with single neurotoxins. The compositions and methods of the invention utilize neurotoxin admixtures calibrated in me ...


3
Eric First, M.D.
Eric R First: toxin treatment for kinesia. Allergan, Claude L Nassif, Stephen Donovan, Martin A Voet, September 18, 2007: US07270287 (14 worldwide citation)

Methods for treating kinesia (motion sickness) by local administration of a Clostridial toxin, such as a botulinum toxin, to a cranial or neck area of a patient susceptible to motion sickness.


4
Eric First, M.D.
Eric R First: Botulinum toxin therapy for skin disorders. Allergan, Hal Gibson, Debra Condino, November 1, 2011: US08048423 (8 worldwide citation)

Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.


5
Eric First, M.D.
Eric R First: Stretch mark treatment. Allergan, Claude L Nassif, Stephen Donovan, Martin Voet, September 30, 2008: US07429386 (7 worldwide citation)

Methods for treating stretch marks by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a stretch mark.


6
Eric First, M.D.
Eric R First: Methods for treating eye disorders. Allergan, Claude L Nassif, Stephen Donovan, Martin Voet, December 16, 2008: US07465458 (6 worldwide citation)

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivi ...


7
Eric First, M.D.
Eric R First: Cosmetic neurotoxin compositions and methods. Allergan, Brigitte C Phan, Ted Chan, Debra Condino, February 11, 2014: US08647639 (5 worldwide citation)

Cosmetic compositions include a Clostridial neurotoxin component and a microsphere component. In certain compositions, the composition includes a botulinum toxin and a plurality of swellable microspheres. The compositions are administered to individuals, by injection and the like, to treat a cosmeti ...


8
Eric First, M.D.
Eric R First: Methods and compositions for treating eye disorders. Allergan, Claude L Hassif, Stephen Donovan, Martin A Voet, May 22, 2007: US07220422 (5 worldwide citation)

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivi ...


9
Eric First, M.D.
Eric R First: Buttock deformity treatment. Allergan, Claude L Nassif, Stephen Donovan, Martin Voet, October 21, 2008: US07438921 (3 worldwide citation)

Methods for treating a buttock deformity or for preventing development of a buttock deformity by local administration of a Clostridial toxin, such as a botulinum neurotoxin, to a buttock deformity or to the vicinity of a buttock deformity.


10
Eric First, M.D.
Eric R First: Methods for treating a buttock deformity. Allergan, Stephen Donovan, February 20, 2007: US07179474 (3 worldwide citation)

Methods for treating a buttock deformity or for preventing development of a buttock deformity by local administration of a Clostridial toxin, such as a botulinum neurotoxin, to a buttock deformity or to the vicinity of a buttock deformity.



Click the thumbnails below to visualize the patent trend.